Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 9, 2024
Distillery Therapeutics

Inhibiting ARRB2 for MASH and MASLD

BioCentury | Feb 21, 2024
Distillery Therapeutics

Increasing Kupffer cell GPR3 activation for obesity

BioCentury | Feb 7, 2020
Translation in Brief

Gilead’s remdesivir vs. 2019-nCov in cells; plus Syndax, Syntrix and Max Planck

BioCentury's roundup of preclinical news
BioCentury | Jan 17, 2018
Distillery Techniques

Drug platforms

BioCentury | Jan 3, 2017
Distillery Therapeutics

Neurology; dermatology

BioCentury | Nov 15, 2016
Distillery Techniques

Chemistry

BioCentury | Sep 15, 2016
Targets & Mechanisms

KOR-recting MS

Why the MS field might invest in biased opioid agonists
BioCentury | Sep 1, 2016
Targets & Mechanisms

Biased against pain

How Epiodyne aims to make opioids safer
Items per page:
1 - 10 of 20